Pacira BioSciences
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Option
RIKER LAUREN BULLARO officer: Vice President, Finance
 Employee Stock Option (right to buy) 10,000 N/A N/A
Option
RIKER LAUREN BULLARO officer: Vice President, Finance
 Common Stock 10,000 N/A N/A
Option
PRATT JOHN officer: General Manager, San D..
 Common Stock 9,375 N/A N/A
Sale
PRATT JOHN officer: General Manager, San D..
 Common Stock 9,375 N/A N/A
Option
PRATT JOHN officer: General Manager, San D..
 Employee Stock Option (right to buy) 9,375 N/A N/A
Sale
HBM BIOVENTURES CAYMAN LTD
Common Stock 500,000 N/A N/A
Sale
SANDERLING VENTURE PARTNERS VI LP 10 percent owner
 Common Stock 348,951 N/A N/A
Sale
MPM BIOVENTURES IV QP LP other: Former 10% Owner
 Common Stock 500,000 N/A N/A
Sale
KAILIAN VAUGHN M other: Former 10% Owner
 Common Stock 500,000 N/A N/A
Sale
EVNIN LUKE director
 Common Stock 500,000 N/A N/A
Sale
WICKI ANDREAS director
 Common Stock 500,000 N/A N/A
Sale
SANDERLING VENTURE PARTNERS VI LP 10 percent owner
 Common Stock 25,560 N/A N/A
Sale
SANDERLING VENTURE PARTNERS VI LP 10 percent owner
 Common Stock 25,560 $25.92 $662,515
Sale
SANDERLING VENTURE PARTNERS VI LP 10 percent owner
 Common Stock 500,000 N/A N/A
Purchase
PACE GARY W director
 Common Stock 10,000 N/A N/A
Sale
ORBIMED ADVISORS LLC 10 percent owner
 Common Stock 63,100 N/A N/A
Sale
ORBIMED ADVISORS LLC 10 percent owner
 Common Stock 37,000 N/A N/A
Sale
ORBIMED ADVISORS LLC 10 percent owner
 Common Stock 3,000 N/A N/A
Sale
ORBIMED ADVISORS LLC 10 percent owner
 Common Stock 10,100 N/A N/A
Sale
ORBIMED ADVISORS LLC 10 percent owner
 Common Stock 29,000 $11.05 $320,363
Sale
ORBIMED ADVISORS LLC 10 percent owner
 Common Stock 300 N/A N/A
Purchase
MPM BIOVENTURES IV QP LP other: Former 10% Owner
 Common Stock 535,714 $7 $3,749,998
Purchase
KAILIAN VAUGHN M other: Former 10% Owner
 Common Stock 535,714 N/A N/A
Purchase
EVNIN LUKE director
 Common Stock 535,714 $7 $3,749,998
Sale
ORBIMED ADVISORS LLC 10 percent owner
 Common Stock 50,000 $10.79 $539,500
Sale
ORBIMED ADVISORS LLC 10 percent owner
 Common Stock 23,300 $10.86 $252,922
Sale
ORBIMED ADVISORS LLC 10 percent owner
 Common Stock 70,000 $11.01 $770,420
Purchase
WICKI ANDREAS director
 Common Stock 307,692 N/A N/A
Purchase
MPM BIOVENTURES IV QP LP other: Former 10% Owner
 Common Stock 461,538 $6.5 $2,999,997
Purchase
EVNIN LUKE director
 Common Stock 461,538 $6.5 $2,999,997
Purchase
KAILIAN VAUGHN M other: Former 10% Owner
 Common Stock 461,538 N/A N/A
Purchase
PACE GARY W director
 Common Stock 7,692 N/A N/A
Purchase
MIDDLETON FRED A director
 Common Stock 10,000 N/A N/A
Purchase
HBM BIOVENTURES CAYMAN LTD
Common Stock 307,692 $6.5 $1,999,998
Sale
ORBIMED ADVISORS LLC 10 percent owner
 Common Stock 97,441 $10.53 $1,025,664
Purchase
SCIBETTA JAMES S officer: President
 Common Stock 5,000 $7.04 $35,200
Purchase
STACK DAVID M director, officer: CEO and Chai..
 Common Stock 5,000 $6.6 $33,000
Purchase
HBM BIOVENTURES CAYMAN LTD
Common Stock 535,714 $7 $3,749,998
Purchase
WICKI ANDREAS director
 Common Stock 535,714 $7 $3,749,998
Purchase
MPM BIOVENTURES IV QP LP other: Former 10% Owner
 Common Stock 535,714 $7 $3,749,998
Purchase
SANDERLING VENTURE PARTNERS VI LP 10 percent owner
 Common Stock 267,857 $7 $1,874,999
Purchase
KAILIAN VAUGHN M other: Former 10% Owner
 Common Stock 535,714 $7 $3,749,998
Purchase
EVNIN LUKE director
 Common Stock 535,714 $7 $3,749,998
Purchase
GORDON CARL L director
 Common Stock 535,714 $7 $3,749,998
Purchase
MIDDLETON FRED A director
 Common Stock 267,857 $7 $1,874,999
Purchase
ORBIMED ADVISORS LLC 10 percent owner
 Common Stock 535,714 $7 $3,749,998

Showing 800 to 846 of 846 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: